This note discusses the medical/therapeutical responses to the COVID-19 pandemic and their 'political economy' context. First, the very quick development of several vaccines highlights the richness of the basic knowledge waiting for therapeutical exploitation. Such knowledge has largely...

This paper is one of the first attempts at empirically identifying organisational capabilities - in this work concerning Italian firms. Together, it proposes new evidence on the link between capabilities and economic performances. In order to do so, we employ the Indagine Multiscopo del...

Lockdown and vaccination policies have been the major concern in the last year in order to contain the SARS-CoV-2 infection during the COVID-19 pandemic. In this paper we present a model able to evaluate alternative lockdown policies and vaccination strategies. Our approach integrates and...

Are IPRs institutions meant to foster innovative activities or conversely to secure appropriation and profitability? Taking stock of a long-term empirical evidence on the pharmaceutical sector in the US, we can hardly support IPRs intended as an innovation rewarding institution. According to our...